Healthcare / Medical - Healthcare Information ServicesUpdated 2026-05-10 22:07 UTC

FRA/4LL stock hub

FRA/4LL has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

FRA/4LLis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.1B

Frankfurt Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

FRA/4LL

In the news

Latest news · FRA/4LL

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 15.7P75 20.2

Trailing P/En/a

P25 16.4P50 20.9P75 30.4

ROE-12.4

P25 -6.7P50 8.5P75 17.2

ROIC-3.6

P25 -1.7P50 8.5P75 17.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All FRA/4LL market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

193

Groups with data

Currency

USD

Showing 193 of 193 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	DE
Employees	5,124
Employees Change	100%
Employees Change Percent	1.82
Enterprise value	EUR 1.4B
Exchange	Frankfurt Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Medical - Healthcare Information Services
Isin	US87918A1051
Last refreshed	2026-05-10
Market cap	EUR 1.1B
Price	EUR 6.14
Price currency	EUR
Rev Per Employee	425,602.09x
Sector	Healthcare
Sic	8090
Symbol	fra/4LL
Website	https://www.teladochealth.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-13.35%
EV Earnings	-9.14x
EV/EBITDA	26.18x
EV/FCF	5.58x
EV/Sales	0.63x
FCF yield	21.85%
P/B ratio	0.96x
P/S ratio	0.51x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-6.25%
EBITDA Margin	1.89%
FCF margin	11.14%
Gross margin	69.29%
Gross Profit	EUR 1.5B
Gross Profit Growth	-3.17%
Gross Profit Growth Q	-3.75%
Gross Profit Growth3 Y	0.36%
Gross Profit Growth5 Y	14.06%
Net Income	EUR -148.4M
Net Income Growth Quarters	2%
Net Income Growth Years	1%
Pretax Margin	-7.36%
Profit Margin	-6.81%
Profit Per Employee	EUR -28,969
ROA	-3.14
Roa5y	-2.32
ROCE	-6.54
ROE	-12.39
Roe5y	-45.49
ROIC	-3.65

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-4.02%
Cagr1y	3.02%
Cagr3y	-36.07%
Cagr5y	-45.15%
EPS Growth Quarters	2
EPS Growth Years	1
FCF Growth	-2.84%
FCF Growth Q	-40.45%
FCF Growth3 Y	8.51%
OCF Growth	-4.23%
OCF Growth Q	-40.22%
OCF Growth3 Y	7.13%
Revenue Growth	-1.5x
Revenue Growth Q	-2.47x
Revenue Growth Years	0x
Revenue Growth3 Y	0.59x
Revenue Growth5 Y	12.97x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.8
Assets	EUR 2.4B
Cash	EUR 651.1M
Current Assets	EUR 960.2M
Current Liabilities	EUR 343.3M
Debt	EUR 900.3M
Debt EBITDA	EUR 17.03
Debt Equity	EUR 0.78
Debt FCF	EUR 3.71
Equity	EUR 1.2B
Interest Coverage	-8.14
Liabilities	EUR 1.3B
Long Term Assets	EUR 1.5B
Long Term Liabilities	EUR 932.4M
Net Cash	EUR -249.2M
Net Cash By Market Cap	EUR -22.41
Net Debt EBITDA	EUR 6.05
Net Debt Equity	EUR 0.22
Net Debt FCF	EUR 1.03
Tangible Book Value	EUR -157.9M
Tangible Book Value Per Share	EUR -0.88

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.8
Inventory Turnover	22.2
Net Working Capital	EUR -11.1M
Quick ratio	2.4
Working Capital	EUR 630.9M
Working Capital Turnover	EUR 3.17

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-3.08%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-33.63%
1Y total return	3.02%
200-day SMA	5.86
3Y total return	-73.88%
50-day SMA	4.75
50-day SMA vs 200-day SMA	50under200
5Y total return	-95.04%
All Time High	252.9
All Time High Change	-97.57%
All Time High Date	2021-02-16
All Time Low	3.71
All Time Low Change	65.3%
All Time Low Date	2026-02-13
ATR	0.24
Ch YTD	3.89
High	6.21
High52	8.41
High52 Date	2025-10-27
High52ch	-27.02%
Low	5.84
Low52	3.71
Low52 Date	2026-02-13
Low52ch	65.3%
Ma50ch	29.18%
Price vs 200-day SMA	4.69%
RSI	66.71
RSI Monthly	36.84
RSI Weekly	55.79
Sharpe ratio	0.2x
Sortino ratio	0.45
Total Return	-3.08%
Tr YTD	3.89
Tr1m	35.6%
Tr1w	8.6%
Tr3m	51.62%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR -136.3M
Operating margin	-6.25

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	179,223,230%
Net Borrowing	-466,912,468.1
Shares Insiders	0.71%
Shares Institutions	74.29%
Shares Qo Q	0.73%
Shares Yo Y	3.08%
Short Ratio	5.3

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR 182.4M
Average Volume	653x
Bv Per Share	6.42
CAPEX	EUR -6.8M
Ch10y	-33.63
Ch1m	35.6
Ch1w	8.6
Ch1y	3.02
Ch3m	51.62
Ch3y	-73.88
Ch5y	-95.04
Ch6m	-6.58
Change	3.47%
Change From Open	4
Close	5.93
Days Gap	-0.51
Depreciation Amortization	173,576,125.5
Dollar Volume	14,763.2
Earnings Date	2026-04-29
EBIT	EUR -136.3M
EBITDA	EUR 41.2M
EPS	EUR -0.84
F Score	4
FCF	EUR 243M
FCF EV Yield	17.92x
Financing CF	-481,238,751
Fiscal Year End	December
Founded	2,002
Goodwill	240,134,358.8
Income Tax	EUR -12.1M
Investing CF	-155,469,596
Is Primary Listing	0
Last Earnings Date	2026-04-29
Last Report Date	2026-03-31
Ma150	5.63
Ma150ch	9.01%
Ma20	5.04
Ma20ch	21.84%
Net CF	-383,861,776
Next Earnings Date	2026-07-28
Open	5.9
P FCF Ratio	4.58
P OCF Ratio	4.45
Position In Range	80
Ppne	42,831,408.6
Price Date	2026-05-08
Price EBITDA	EUR 26.98
Relative Volume	3.31x
Revenue	2,180,785,087x
SBC By Revenue	2.78x
Share Based Comp	60,591,313
Tax By Revenue	-0.56x
Tr6m	-6.58%
Volume	2,406
Z Score	-6.69

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does FRA/4LL pay a dividend?

Capital-return profile for this ticker.

Performance

FRA/4LL stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns FRA/4LL?

Insider, institutional, and short-interest positioning.

Institutional ownership

+74.3%

Share of float held by funds and institutions

Insider ownership

+0.7%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

FRA/4LL momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

66.7

Neutral momentum band

Price vs 200-day MA

+4.7%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

0.20

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About FRA/4LL

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/4LL stock rating?

fra/4LL is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/4LL analysis?

The full report lives at /stocks/fra/4LL/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/4LL?

The latest report frames fra/4LL around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/4LL page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.